TISSUE & FFPE COHORT COLLECTIONS

Lung cancer tissue microarrays & FFPE blocks

Explore NSCLC and SCLC arrays by histology, molecular profile and treatment context. Compare adenocarcinoma and squamous cell carcinoma collections, matched tissue, and selected clinical or molecular datasets. For FFPE blocks, share your tissue and study requirements with our team.

THE ARRAYS

Lung cancer arrays (19)

Collection types in this TMA catalog

Explore the tissue composition and sampling groups represented in these arrays.

Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.

FFPE TISSUE BLOCKS

Lung cancer FFPE blocks for your study

Explore NSCLC FFPE cohorts defined by EGFR, ROS1, PD-L1 or treatment setting, alongside separate small-cell lung cancer and neuroendocrine carcinoma profiles.

FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.

Explore NSCLC FFPE cohort profiles

Collection features

  • Advanced disease (III/IV)
  • Longitudinal data
  • Primary & matched metastases
  • Pre / post standard-of-care treatment
  • Pre / post immunotherapy

Features vary by profile and donor; confirm the required coverage for your study.

Explore Small-cell lung cancer & neuroendocrine carcinoma FFPE cohort profiles

Poorly differentiated neuroendocrine carcinoma, including SCLC, large-cell neuroendocrine carcinoma (LCNEC) and extrapulmonary NEC

Inquire about this cohort

Profiles describe documented collections, not live inventory. Features vary by profile and donor. Pre/post treatment collections are not necessarily donor-matched; availability and required coverage are confirmed for your study.

SELECTING YOUR ARRAY

Match lung histology, markers and treatment context

A marker-defined array and a treatment-follow-up array answer different selection needs. Review the tissue and the associated records together.

Histology and molecular groups

TA2893 is a small cell lung cancer collection with follow-up. For NSCLC, TA4322 includes EGFR-mutated and wild-type tissue, while TA4323 uses KRAS status to define its listed groups. Histopathology and molecular coverage vary by array.

Treatment setting and donor matching

TA3111 contains donor-matched pre- and post-treatment NSCLC samples. Other pre/post collections are explicitly not donor matched. TA4301 is listed with second-line immunotherapy follow-up; the treatment setting should be checked at case level.

Included records versus optional datasets

TA4301 lists RNA-seq, GeoMx protein/RNA and DAB IHC data as optional. TA4327 lists PD-L1 and Oncomine Precision Assay NGS data with optional follow-up. Do not assume one array's data package applies to another.